A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease Read more about A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease
Walkbot Robotic Training for Improvement in Gait Read more about Walkbot Robotic Training for Improvement in Gait
CHALO! 2.0: A Mobile Technology Based Intervention to Accelerate HIV Testing and Linkage to Preventive Treatment. Read more about CHALO! 2.0: A Mobile Technology Based Intervention to Accelerate HIV Testing and Linkage to Preventive Treatment.
Reducing Lung CongestIon Symptoms in Advanced Heart Failure Read more about Reducing Lung CongestIon Symptoms in Advanced Heart Failure
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Read more about Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia Read more about Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Read more about A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Read more about 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU) Read more about Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)
Novel INXN-4001 Triple Effector Plasmid in Heart Failure Read more about Novel INXN-4001 Triple Effector Plasmid in Heart Failure